Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2012-09-17
AEs
3
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild APPLICATION SITE DESQUAMATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-24 (study day 130.0); relationship: POSSIBLE
mild
assessed
Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-22 (study day 97.0); relationship: POSSIBLE
mild
assessed
Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2012-12-22 (study day 97.0); relationship: POSSIBLE
Data queries
No data queries.